Clinical Trial Update: Comparing Bivalirudin Versus Heparin/ GP IIB/IIA in Patients Undergoing PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing bivalirudin with heparin plus GP IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention; current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Bivalirudin (bivalirudin)
• Heparin (unfractionated heparin)

Snippet

Sponsor: Gold, Herman K., MD | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN